Perceptive Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Perceptive Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $12.7 Million - $14.6 Million	-75,898 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $11.1 Million - $12.9 Million	-76,000 Reduced 50.03%	75,898 $12.9 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $2.01 Million - $2.35 Million	13,272 Added 9.57%	151,898 $24.8 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $20.5 Million - $22.5 Million	138,626	138,626 $21.1 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.